Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice
David R. Martinez, Alexandra Schäfer, Tyler D. Gavitt, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113248-113248
Open Access | Times Cited: 11

Showing 11 citing articles:

In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms
S. Cankat, M. U. Demael, Leo Swadling
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 103-118
Open Access | Times Cited: 24
Sortases: structure, mechanism, and implications for protein engineering
Jeanine F. Amacher, John M. Antos
Trends in Biochemical Sciences (2024) Vol. 49, Iss. 7, pp. 596-610
Closed Access | Times Cited: 6
Sustained exposure to multivalent antigen-decorated nanoparticles generates broad anti-coronavirus responses
Julie Baillet, John H. Klich, Ben S. Ou, et al.
Matter (2025), pp. 102006-102006
Open Access
Divergent pathogenetic outcomes in BALB/c mice following Omicron subvariant infection
John M. Powers, Sarah R. Leist, Michael L. Mallory, et al.
Virus Research (2024) Vol. 341, pp. 199319-199319
Open Access | Times Cited: 2
Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV
Cara W. Chao, Kaitlin R. Sprouse, Marcos C. Miranda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV
Cara W. Chao, Kaitlin R. Sprouse, Marcos C. Miranda, et al.
Cell Reports (2024) Vol. 43, Iss. 12, pp. 115036-115036
Open Access | Times Cited: 2
Causes and Consequences of Coronavirus Spike Protein Variability
Fabian Zech, Christoph Jung, Timo Jacob, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 177-177
Open Access
A Cocktail of Lipid Nanoparticle-mRNA Vaccines Broaden Immune Responses against β-Coronaviruses in a Murine Model
Yi Zhang, Jialu Zhang, Dongmei Li, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 484-484
Open Access
Sustained exposure to multivalent antigen-decorated nanoparticles generates broad anti-coronavirus responses
Julie Baillet, John H. Klich, Ben S. Ou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Challenges for developing broad-based mucosal vaccines for respiratory viruses
Jung Hwa Seo, J. Polster, Benjamin Israelow, et al.
Nature Biotechnology (2024)
Closed Access
100 Day Vaccine Development – An Alternative ApproachBoosters for Phase III Trialed Viral Family Vaccines
Robert R. Martín
(2023)
Open Access | Times Cited: 1
Page 1

Scroll to top